Trump inks deal with 9 pharmaceutical companies to lower drug costs

The White House said the agreements will reduce costs to treat Parkinson's disease, macular degeneration, glaucoma, liver disease and other illnesses.

Original reporting by CBS News. GridIndex is an aggregation and intelligence layer — full credit to the original publisher.